| Product Code: ETC7333178 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ghana Oncology NGS Market Overview |
3.1 Ghana Country Macro Economic Indicators |
3.2 Ghana Oncology NGS Market Revenues & Volume, 2021 & 2031F |
3.3 Ghana Oncology NGS Market - Industry Life Cycle |
3.4 Ghana Oncology NGS Market - Porter's Five Forces |
3.5 Ghana Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Ghana Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Ghana Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.8 Ghana Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.9 Ghana Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Ghana Oncology NGS Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Ghana |
4.2.2 Growing awareness about the benefits of Next-Generation Sequencing (NGS) technology in oncology |
4.2.3 Government initiatives to improve cancer care and diagnosis in the country |
4.3 Market Restraints |
4.3.1 High cost associated with NGS technology and testing |
4.3.2 Limited access to advanced healthcare facilities in certain regions of Ghana |
4.3.3 Lack of skilled professionals in oncology and genomics fields |
5 Ghana Oncology NGS Market Trends |
6 Ghana Oncology NGS Market, By Types |
6.1 Ghana Oncology NGS Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Ghana Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Ghana Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Ghana Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.2 Ghana Oncology NGS Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Ghana Oncology NGS Market Revenues & Volume, By Diagnostics and Screening, 2021- 2031F |
6.2.3 Ghana Oncology NGS Market Revenues & Volume, By Research Studies, 2021- 2031F |
6.3 Ghana Oncology NGS Market, By Service |
6.3.1 Overview and Analysis |
6.3.2 Ghana Oncology NGS Market Revenues & Volume, By Platforms and Related Products, 2021- 2031F |
6.3.3 Ghana Oncology NGS Market Revenues & Volume, By Services, 2021- 2031F |
6.4 Ghana Oncology NGS Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 Ghana Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F |
6.4.3 Ghana Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.4.4 Ghana Oncology NGS Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F |
6.5 Ghana Oncology NGS Market, By End-use |
6.5.1 Overview and Analysis |
6.5.2 Ghana Oncology NGS Market Revenues & Volume, By Academic Research, 2021- 2031F |
6.5.3 Ghana Oncology NGS Market Revenues & Volume, By Clinical Research, 2021- 2031F |
6.5.4 Ghana Oncology NGS Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.5.5 Ghana Oncology NGS Market Revenues & Volume, By Pharma & Biotech Entities, 2021- 2031F |
6.5.6 Ghana Oncology NGS Market Revenues & Volume, By Other users, 2021- 2031F |
7 Ghana Oncology NGS Market Import-Export Trade Statistics |
7.1 Ghana Oncology NGS Market Export to Major Countries |
7.2 Ghana Oncology NGS Market Imports from Major Countries |
8 Ghana Oncology NGS Market Key Performance Indicators |
8.1 Number of oncology NGS tests conducted annually in Ghana |
8.2 Adoption rate of NGS technology in oncology practices |
8.3 Number of research collaborations between local institutions and international organizations in the field of oncology NGS |
9 Ghana Oncology NGS Market - Opportunity Assessment |
9.1 Ghana Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Ghana Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Ghana Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F |
9.4 Ghana Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.5 Ghana Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Ghana Oncology NGS Market - Competitive Landscape |
10.1 Ghana Oncology NGS Market Revenue Share, By Companies, 2024 |
10.2 Ghana Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here